2012Zhongguo tangniaobing zazhiRequires access

The therapeutic effect of the combination of metformin and rosiglitazone in patients with polycystic ovary syndrome

LU Xue-ling

Open publisher page 0 citations

Abstract

Objective To observe the therapeutic effect of combination of metformin and rosiglitazone in women with polycystic ovarian syndrome(PCOS).Methods 68 patients with PCOS were divided into two groups of treatment: metformin alone,rosiglitazone and metformin combination.All patients were followed for 6 months.Results BMI,waist circumference(WC) and insulin level decreased after treatment.The insulin level decrement was more in combination group than in metformin group(P0.05) And there were more patients presenting with menstrual onset recovery in combination treatment group versus metformin alone. Conclusions Insulin resistance can be improved more with combination treatment,and menstrual onset recovers earlier in combination group,too.

About this research paper

What this paper is about

Objective To observe the therapeutic effect of combination of metformin and rosiglitazone in women with polycystic ovarian syndrome(PCOS).Methods 68 patients with PCOS were divided into two groups of treatment: metformin alone,rosiglitazone and metformin combination.All patients were followed for 6 months.Results BMI,waist circumference(WC) and insulin level decreased after treatment.The insulin level decrement was more in combination group than in metformin group(P0.05) And there were more patients presenting with menstrual onset recovery in combination treatment group versus metformin alone. Conclusions Insulin resistance can be improved more with combination treatment,and menstrual onset recovers earlier in combination group,too.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To observe the therapeutic effect of combination of metformin and rosiglitazone in women with polycystic ovarian syndrome(PCOS).Methods 68 patients with PCOS were divided into two groups of treatment: metformin alone,rosiglitazone and metformin combination.All patients were followed for 6 months.Results BMI,waist circumference(WC) and insulin level decreased after treatment.The insulin level decrement was more in combination group than in metformin group(P0.05) And there were more patients presenting with menstrual onset recovery in combination treatment group versus metformin alone. Conclusions Insulin resistance can be improved more with combination treatment,and menstrual onset recovers earlier in combination group,too.

Key concepts: Metformin, Rosiglitazone, Medicine, Polycystic ovary, Internal medicine, Waist, Insulin resistance, Therapeutic effect

Related papers

Back to paper searchBrowse research topicsOriginal source
The therapeutic effect of the combination of metformin and rosiglitazone in patients with polycystic ovary syndrome — Research Paper | ScholarLens